Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity

Víctor Moreno-Torres, Ana Royuela, Guillem Policarpo-Torres, Diana Paredes Ruiz, María Calabuig, Isabel Sánchez Berná, Olga Capdevila Pons, Augustín Colodro, José Salvador García-Morillo, Lucio Pallarés, Luis Trapiella, Adela Marin Ballvé, Cristina Lavilla-Olleros, Jose Luis Callejas-Rubio, Fernando Tornero, Sandra Parra, Ignasi Rodríguez-Pintó, Julia Barbado Ajo, Ismael Calero-Paniagua, Esther Rubio, Ana Argibay, José M Gómez-Verdú, Jesús Miguel López-Dupla, Carlos Jorge Ripper, Angel Robles-Marhuenda, Eva Calvo-Begueria, Eva Fonseca, Andrés González-García, Kima López-Aldabe, Begoña Frutos- Pérez, Robert Hurtado-García, Ana Ponce, Gabriela Artinyan, Angel Pedro Crisolino Pozas, Borja De Miguel-Campo, Joaquín Pousibet, Gerard Espinosa

Open source

DOI: 10.1136/lupus-2026-001980
Published: 2026-07
Container: Lupus Science & Medicine
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/lupus-2026-001980,
  title = {Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity},
  author = {Víctor Moreno-Torres and Ana Royuela and Guillem Policarpo-Torres and Diana Paredes Ruiz and María Calabuig and Isabel Sánchez Berná and Olga Capdevila Pons and Augustín Colodro and José Salvador García-Morillo and Lucio Pallarés and Luis Trapiella and Adela Marin Ballvé and Cristina Lavilla-Olleros and Jose Luis Callejas-Rubio and Fernando Tornero and Sandra Parra and Ignasi Rodríguez-Pintó and Julia Barbado Ajo and Ismael Calero-Paniagua and Esther Rubio and Ana Argibay and José M Gómez-Verdú and Jesús Miguel López-Dupla and Carlos Jorge Ripper and Angel Robles-Marhuenda and Eva Calvo-Begueria and Eva Fonseca and Andrés González-García and Kima López-Aldabe and Begoña Frutos- Pérez and Robert Hurtado-García and Ana Ponce and Gabriela Artinyan and Angel Pedro Crisolino Pozas and Borja De Miguel-Campo and Joaquín Pousibet and Gerard Espinosa},
  year = {2026},
  journal = {Lupus Science \&amp; Medicine},
  doi = {10.1136/lupus-2026-001980},
  url = {https://doi.org/10.1136/lupus-2026-001980}
}

RIS

TY  - JOUR
TI  - Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity
AU  - Víctor Moreno-Torres
AU  - Ana Royuela
AU  - Guillem Policarpo-Torres
AU  - Diana Paredes Ruiz
AU  - María Calabuig
AU  - Isabel Sánchez Berná
AU  - Olga Capdevila Pons
AU  - Augustín Colodro
AU  - José Salvador García-Morillo
AU  - Lucio Pallarés
AU  - Luis Trapiella
AU  - Adela Marin Ballvé
AU  - Cristina Lavilla-Olleros
AU  - Jose Luis Callejas-Rubio
AU  - Fernando Tornero
AU  - Sandra Parra
AU  - Ignasi Rodríguez-Pintó
AU  - Julia Barbado Ajo
AU  - Ismael Calero-Paniagua
AU  - Esther Rubio
AU  - Ana Argibay
AU  - José M Gómez-Verdú
AU  - Jesús Miguel López-Dupla
AU  - Carlos Jorge Ripper
AU  - Angel Robles-Marhuenda
AU  - Eva Calvo-Begueria
AU  - Eva Fonseca
AU  - Andrés González-García
AU  - Kima López-Aldabe
AU  - Begoña Frutos- Pérez
AU  - Robert Hurtado-García
AU  - Ana Ponce
AU  - Gabriela Artinyan
AU  - Angel Pedro Crisolino Pozas
AU  - Borja De Miguel-Campo
AU  - Joaquín Pousibet
AU  - Gerard Espinosa
PY  - 2026
JO  - Lupus Science &amp; Medicine
DO  - 10.1136/lupus-2026-001980
UR  - https://doi.org/10.1136/lupus-2026-001980
ER  -

APA

Moreno-Torres, V., Royuela, A., Policarpo-Torres, G., Ruiz, D. P., Calabuig, M., Berná, I. S., Pons, O. C., Colodro, A., García-Morillo, J. S., Pallarés, L., Trapiella, L., Ballvé, A. M., Lavilla-Olleros, C., Callejas-Rubio, J. L., Tornero, F., Parra, S., Rodríguez-Pintó, I., Ajo, J. B., Calero-Paniagua, I., Rubio, E., Argibay, A., Gómez-Verdú, J. M., López-Dupla, J. M., Ripper, C. J., Robles-Marhuenda, A., Calvo-Begueria, E., Fonseca, E., González-García, A., López-Aldabe, K., Pérez, B. F., Hurtado-García, R., Ponce, A., Artinyan, G., Pozas, A. P. C., Miguel-Campo, B. D., Pousibet, J., & Espinosa, G. (2026). Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity. Lupus Science & Medicine. https://doi.org/10.1136/lupus-2026-001980

Source records

crossref · retrieved 2026-11-10T13:10:28.987Z